Carbon Monoxide Receptacle With External Activation and Permeable Wall

The patent extracts the gas permeable membrane from the device structure, allowing carbon monoxide to diffuse directly through the housing walls without requiring an internal membrane barrier. This eliminates the complex two-compartment construction while maintaining the carbon monoxide release function through direct diffusion of the gas through the housing material.

The patent merges the functions of the membrane and housing into a single integrated structure where the housing itself serves as the diffusion barrier. The activation substance and carbon monoxide releasing molecules are combined in a single chamber rather than separate compartments, simplifying the overall device architecture while maintaining controlled release.

The patent removes the inner septum and activation substance from the device structure, storing only the carbon monoxide releasing molecules within the housing. The activation substance is administered externally, eliminating the need for internal separation mechanisms and reducing structural complexity while maintaining substance separation through external administration.

Instead of storing both substances internally and separating them with a membrane, the patent inverts the approach by storing only the carbon monoxide releasing molecules internally and introducing the activation substance externally. This reversal eliminates the need for internal separation structures while achieving the same functional outcome.

The patent uses carbon dioxide as an intermediary carrier gas that diffuses through the housing wall and carries carbon monoxide molecules to the treatment site. This intermediary approach allows controlled local delivery of carbon monoxide without direct inhalation, reducing systemic toxicity while maintaining therapeutic effectiveness at the target location.

The patent employs carbon dioxide, a naturally occurring and safe gas, as a template or carrier that mimics the delivery function of inhalation but without the harmful effects. The carbon dioxide carrier system reproduces the beneficial gas delivery mechanism while eliminating the toxic binding with hemoglobin.

The patent removes the complex multi-component structure including internal membranes, septa, and multiple compartments, leaving only a simple housing containing carbon monoxide releasing molecules. This extracted simplified design dramatically reduces manufacturing steps, material requirements, and assembly complexity while maintaining the core carbon monoxide release functionality.

The patent combines multiple discrete components (housing, membrane, septum, multiple chambers) into a single integrated housing structure. This merging of functions into one component reduces the number of manufacturing steps, eliminates assembly operations, and simplifies quality control while preserving the essential carbon monoxide delivery capability.